For the purpose of biological screening, a number of new quinoxalines have been synthesized via fluorine replacement in 2,3-disubstituted 6,7-difluoroquinoxaline 1,4-dioxides and their deoxygenated derivatives by reactions with dialkylamines, sodium azide, and sodium methoxide.
1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1956020A2
公开(公告)日:2008-08-13
This invention relates to N-aroyl cyclic amine derivatives and their use as pharmaceuticals.
本发明涉及 N-芳酰基环胺衍生物及其作为药物的用途。
——
作者:S. K. Kotovskaya、S. A. Romanova、V. N. Charushin、O. N. Chupakhin
DOI:10.1023/a:1020870100148
日期:——
For the purpose of biological screening, a number of new quinoxalines have been synthesized via fluorine replacement in 2,3-disubstituted 6,7-difluoroquinoxaline 1,4-dioxides and their deoxygenated derivatives by reactions with dialkylamines, sodium azide, and sodium methoxide.